- TheStreet.com•1 hour ago
Icahn may have a tough time finding interest in this behemoth.
- Zacks•3 hours ago
Could Bristol-Myers Squibb Company (BMY) soon be put on the market for sale as activist investor, Carl Icahn, takes interest in the company?
- Investor's Business Daily•4 hours ago
Gilead and GSK will have a tough time divorcing HIV patients from their traditional three-pill regimens, Leerink said Wednesday,
MRK : Summary for Merck & Company, Inc. Common St - Yahoo Finance
Merck & Co., Inc. (MRK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||65.09 - 65.75|
|52 Week Range||49.63 - 65.87|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.00|
|Dividend & Yield||1.88 (2.88%)|
|1y Target Est||N/A|